# OnCo record miles-prince (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/miles-prince/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "miles-prince" ;
  schema:name "H. Miles Prince"@en ;
  schema:description "Melbourne haematologist who led ALCANZA, the trial that showed brentuximab vedotin beats standard treatment for CD30-expressing cutaneous T-cell lymphoma."@en ;
  schema:url <https://onco.cc/people/miles-prince/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "lymphoma", "trialist" ;
  schema:jobTitle "Haematologist, Peter MacCallum Cancer Centre and Epworth Healthcare, Melbourne" ;
  onco:cancers <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> ;
  onco:institutions <https://onco.cc/institutions/peter-mac/> ;
  onco:trials <https://onco.cc/trials/alcanza/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-alcanza-brentuximab-vedotin-lancet-2017/> ;
  schema:affiliation <https://onco.cc/institutions/peter-mac/> .